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PPARd Activation Promotes Stratum Corneum
Formation and Epidermal Permeability Barrier
Development during Late Gestation
Yan J. Jiang1, Grant Barish2, Biao Lu1, Ronald M. Evans2, Debra Crumrine3, Matthias Schmuth3,
Peter M. Elias3 and Kenneth R. Feingold1,3
The goal of epidermal ontogenesis is to form a stratum corneum (SC), which is required for post-natal
permeability barrier function. The regulation of epidermal ontogenesis is poorly understood, but nuclear
hormone receptors have been shown to have an important function. As peroxisome proliferator-activated
receptor-d (PPARd) is very abundant in fetal epidermis and PPARd activation stimulates differentiation and
permeability barrier formation in adults, we hypothesized that PPARd might regulate epidermal ontogenesis.
Treatment of fetal rat explants with the PPARd ligand, GW 610742X, accelerates permeability barrier
development, evidenced by a decrease in transepidermal water loss and an enhanced outside-in barrier
function, attributable to the presence of more mature lamellar membranes in the SC and enhanced expression
of loricrin and involucrin. Similarly, the intra-amniotic administration of GW 610742X also accelerates the
formation of the SC and permeability barrier development. Finally, in PPARd-deficient mice the formation of the
SC and the expression of differentiation-related proteins were delayed on days 16.5 and 17.5 of gestation.
However, at later stages (day 18.5 and after birth), there were no differences between wild-type- and PPARd-
deficient mice, indicating only a transient delay in epidermal ontogenesis. These studies show that PPARd has a
role in SC formation and permeability barrier development.
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INTRODUCTION
It is essential that before birth the skin forms a competent
barrier, separating the outside hostile environment from the
organism. One of the key barrier properties of the skin is the
obstruction of the movement of water and electrolytes, that is,
the permeability barrier. Without a competent permeability
barrier, increased water loss occurs, leading to disturbances
in fluid and electrolyte balance and hypothermia due to
evaporative heat loss. Full-term infants have a normal
permeability barrier with transepidermal water loss (TEWL)
similar to that observed in adults (Hammarlund and Sedin,
1979; Harpin and Rutter, 1983). However, premature infants
(o33 weeks gestation) show both increased TEWL and
enhanced absorption of xenobiotics, indicative of abnormal
permeability barrier function (Hammarlund and Sedin, 1979;
Harpin and Rutter, 1983). This permeability barrier abnorm-
ality is a major source of morbidity and even mortality in very
premature infants (o28 weeks gestation) (Cartlidge and
Stewart, 1995).
The permeability barrier is localized to the outer layer of
the epidermis, the stratum corneum (SC) (Elias and Menon,
1991; Feingold, 2007). The SC consists of corneocytes,
keratinocytes (Kers) that have undergone terminal differentia-
tion, surrounded by a neutral lipid-enriched extracellular
matrix. The hydrophobic, extracellular lipid matrix provides
the principal barrier to the transcutaneous movement of
water and electrolytes. These lipid-enriched lamellar mem-
branes in the SC contain predominantly cholesterol (CHOL),
free fatty acids, and ceramides, which are derived from the
exocytosis of lamellar body (LB) contents from the outermost
stratum granulosum (SG) cells. However, the corneocytes
provide a scaffold for these extracellular lipids, and therefore,
abnormalities in corneocyte structure can also alter perme-
ability barrier function. Keratinocytes undergo a complex
pathway of differentiation, which culminates in Ker cornifi-
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cation and in the formation of extracellular lipid-enriched
lamellar membranes in the SC (Fuchs, 1990; Eckert et al.,
1997).
The SC and the permeability barrier develop late during
the third trimester in both humans (Foster et al., 1988) and in
rodents. In the fetal rat a competent barrier is not present at
day 19 of their 22 day gestation period (Aszterbaum et al.,
1992). However, by day 21, just before birth, a competent
permeability barrier is formed. The emergence of a functional
permeability barrier correlates with both the appearance of a
multilayered SC and the formation of mature lamellar
membranes in the SC interstices (Aszterbaum et al., 1992).
Moreover, structural proteins required for corneocyte forma-
tion, such as loricrin (LOR), filaggrin (FIL), and involucrin
(INV), increase late in gestation in parallel with permeability
barrier formation. The factors that regulate fetal SC develop-
ment and permeability barrier formation are not well under-
stood. Previous studies have shown that glucocorticoids,
estrogen, and thyroid hormone stimulate, while testosterone
delays SC formation and permeability barrier development
(Aszterbaum et al., 1992, 1993; Hanley et al., 1996a, 1996b,
1997a, 1997b, 1998a).
Activators of peroxisome proliferator-activated receptor
(PPAR)-a, -d, and -g have numerous effects on epidermal
structure and function (Kuenzli and Saurat, 2003; Schmuth
et al., 2008). The addition of PPAR (a, d, and g) activators
to cultured human Kers, and the topical application of
these activators to adult mouse skin stimulate the expression
of INV, LOR, and profilaggrin (Hanley et al., 1998b;
Komuves et al., 2000; Westergaard et al., 2001; Schmuth
et al., 2004), which are required for corneocyte formation. In
addition, topical treatment of adult murine skin with PPAR (a,
d, and g) activators improves permeability barrier home-
ostasis, due at least in part to increased LB density and
secretion (Man et al., 2006). In previous studies we have
shown that activators of PPARa, but not PPARg, stimulate
fetal SC development and permeability barrier formation
in both a fetal skin explant model that mimics intrauterine
skin development, and following intra-amniotic administra-
tion (Hanley et al., 1997b, 1999). Moreover, PPARa-
deficient mice show a transient delay in the formation
of the SC and a modest decrease in the expression of
both INV and LOR, markers of Ker differentiation (Schmuth
et al., 2002). However, at birth, the SC and permeability
barrier are normal in PPARa-deficient mice (Schmuth et al.,
2002).
Peroxisome proliferator-activated receptor-d is the most
abundant isoform of PPAR expressed in fetal epidermis
(Braissant and Wahli, 1998; Michalik et al., 2001). We
therefore hypothesized that activation of PPARd would have
an important function in regulating fetal SC formation and
permeability barrier development. In this article, we show
that PPARd activation stimulates SC formation and perme-
ability barrier development in both the fetal skin explant
model and following intra-amniotic administration. In addi-
tion, we show a delay in fetal SC formation in mice deficient
in PPARd, indicating that PPARd has a function in barrier
ontogenesis.
RESULTS
Activation of PPARd accelerates SC formation in the fetal skin
explant model
Our initial experiments determined the effect of the PPARd
activator, GW 610742X, on permeability barrier function.
Skin explants from day 17 fetal rats were incubated in the
presence of either GW 610742X or vehicle, and TEWL was
measured gravimetrically after 2 days, as previously de-
scribed (Hanley et al., 1996c). As shown in Figure 1, GW
610742X treatment significantly reduced TEWL at 2 and
5 hours, compared with vehicle control (Po0.05, n¼5–6),
indicating that PPARd activation stimulates permeability
barrier formation in fetal rat explants.
To investigate the basis for these functional changes, we
next assessed the histological alterations in the epidermis of
fetal rat explants following treatment with the PPARd
activator. During the third trimester (days 17–21), rat
epidermis displays a dramatic change in morphology (Aszter-
baum et al., 1992) with a marked increase in the number of
epidermal cell layers of the epidermis and the appearance of a
SC. In parallel with these morphological changes, several Ker
differentiation markers, including INV, LOR, and FIL, are
expressed in the rat epidermis on days 17, 19, and 20,
respectively (Bickenbach et al., 1995; Hardman et al., 1998).
Consistent with our previous report (Aszterbaum et al., 1992),
after 2 days of incubation, skin explants from 17 day fetal rats
(days 17þ 2) lacked a multilayered SG and a distinct SC, a
pattern corresponding to day 19 of gestation (Supplementary
Figure S1, a). In contrast, both a multilayered SG and layers of
distinct SC were present in epidermis incubated with GW
610742X (Supplementary Figure S1, b-c). These results
indicate that the acceleration in permeability barrier forma-
tion induced by PPARd activation is associated with the
appearance of more mature epidermal morphology.
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Figure 1. Peroxisome proliferator-activated receptor-d (PPARd) activation
accelerates epidermal permeability barrier formation. Explants from day 17
fetal rat were incubated in the presence of GW 610742X (100 mM) or vehicle
(DMSO) for 2 days. The gravimetric transepidermal water loss (TEWL)
(mg mm2 hour1) of explants was determined as described in the Materials
and Methods section. Data are presented as mean±SD (n¼ 5–6; *Po0.05),
and calculated by subtraction of the weight at 2 hours (TEWL 2 hours) at
5 hours (TEWL 5 hours) from the initial weight at 0 hour. Similar results were
obtained when the experiment was repeated twice with epidermal samples
prepared from different batches of fetal rats.
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To determine whether the accelerated SC formation in
fetal explants is accompanied by an increase in the
expression of structural proteins (differentiation markers)
necessary for corneocyte formation, we next examined the
levels of INV and LOR in fetal rat epidermis by immunohis-
tochemistry. Although both INV and LOR were absent in the
epidermis from control explants (Supplementary Figure S1, d,
g), they were easily detected in explants treated with GW
610742X (Supplementary Figure S1, e-f, h-i). FIL was
undetectable in both control and GW 610742X-treated
explants (data not shown). Together, our results indicate that
activation of PPARd stimulates the expression of certain
structural proteins required for SC formation.
We next evaluated the ultrastructural appearance of the
outer epidermis. As shown in Figure 2, although vehicle-
treated explants (Figure 2a) again failed to reveal SC
formation, SC was apparent in GW 610742X-treated explants
(typically two layers) (Figure 2c). Moreover, LB secretion
appeared increased in GW 610742X-treated explants (Figure
2d, arrows), and lamellar membranes was evident at the
SG–SC interface (Figure 2e, arrows), compared with control
(Figure 2b, arrows). These results indicate that PPARd
activation stimulates maturation of both the cellular and
extracellular compartments of SC.
To further investigate outside-in barrier function following
PPARd ligand treatment, we next examined the transepider-
mal diffusion of the fluorescent dye Lucifer yellow in the
explants. As shown in Supplementary Figure S2, the dye was
found not only to diffuse through all layers of epidermis but
was even detectable in the dermis in the control explants
(Figure 2a, arrows). In contrast, the dye was mainly restrained
in the upper layers of the SC in the GW 610742X-treated
explants (Figure 2b, arrows), indicting an accelerated barrier
formation in these explants.
Intra-amniotic administration of PPARd activator accelerate SC
development
We next determined whether the intra-amniotic administra-
tion of GW 610742X would accelerate permeability barrier
formation in vivo. As shown in Figure 3, similar to our results
in the fetal skin explant model, intra-amniotic administration
of GW 610742X caused a decline in TEWL, indicating that
PPARd activation accelerates permeability barrier formation
in the fetal rat skin. We next examined the morphology of the
epidermis using light microscopy, and observed that the
epidermis of GW 610742X-treated fetuses revealed a more
mature epidermis with a multilayered SG and a distinct SC
with hematoxylin and eosin (H&E) staining (Supplementary
Figure S3, b vs a). Similarly, treatment with GW 610742X
also increased the expression of INV and LOR in epidermis
(Supplementary Figure S3, d, f). FIL was undetectable in both
vehicle- and GW 610742X-treated fetal rats (data not shown).
In addition, a more mature epidermis, with abundant LB
secretion (Figure 4d) and lamellar bilayer formation
(Figure 4c) was also evident in the extracellular spaces of
the SC of GW 610742X-treated fetal rats by electron
microscopy (EM). In contrast, the epidermis from vehicle-
treated animals had less LB secretion (Figure 4a), with 1–2
layers of SC (Figure 4b). Finally, when epidermis was stained
with nile red, a dye that differentially stains neutral lipids in
yellow and polar lipids in red, there were intensive yellow
staining in SC layers (Supplementary Figure S4, b) and some
red staining in SG layers (Supplementary Figure S4, b, insert)
of GW 610742X-treated fetal rat, compared with mostly red
staining in vehicle controls (Supplementary Figure S4, a). The
hallmark of mature SC is its neutral lipid composition. It is
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Figure 2. PPARd activation accelerates stratum corneum formation and
epidermal barrier development in fetal rat explants. Explants from day
17 fetal rat were incubated with GW 610742X (100 mM) or vehicle for 2 days,
and electron microscope analysis was performed as described in Materials
and Methods section. Vehicle control (aþ b). Early stratum corneum (SC)
formation is seen, as well as evidence of secretion of lamellar body (LB)
contents at the SC–stratum granulosum (SG) interface (arrows). Bar¼1 mm (a),
0.2mm (b). GW 610742X-treated (c-e). A small increase in SC formation is
evident (one more layer of SC; c), but a much greater quantity of LB contents
are present at SG–SC interface (d, arrows). Moreover, there is early evidence
of lamellar bilayer formation (e, arrows). Note GW 610742X-treated explants
display improved LB secretion and post-secretory lipid processing. Bar¼ 1 mm
(a, c, d), 0.2mm (b, e). Veh: vehicle.
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Figure 3. Intra-amniotic administration of PPARd activator accelerates fetal
epidermal permeability barrier formation in vivo. At day 17 of gestation,
timed-pregnant Sprague–Dawley (SD) rats were injected intra-amniotically
with either GW 610742X or vehicle, and transepidermal water loss (TEWL)
was measured in fetal rat epidermis on gestational day 19, as described in
Materials and Methods section. Results are expressed as the mean±SD (n¼ 7;
***Po0.001). Similar results were obtained when experiments were repeated
with an additional batch of pregnant rats.
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worth noting that there appeared a slightly increased
epidermal thickness on light microscopy of H&E- and nile
red-stained sections of fetal rats after amniotic fluid injection
with GW 610742X (Supplementary Figure S3, a-b; Supple-
mentary Figure S4). However, this increase is mainly due to
the increased layers of SG and SC, because when the distance
between the basement lamina and the lower SC was
quantified, we did not find any difference in epidermal
thickness of the GW 61072X-treated versus vehicle control
groups (data not shown). Similar phenomena were observed
in the epidermis of adult mice topically treated with PPARd
ligand following barrier disruption (Schmuth et al., 2004).
These observations confirm the results in the fetal skin
explant model, and together clearly show that PPARd
activation accelerates SC formation and permeability barrier
development.
Delayed SC formation in PPARd-deficient mice
Although the studies described above show that pharmaco-
logical activation of PPARd accelerates fetal epidermal/SC
development, they do not address the potential importance of
endogenous PPARd activation for epidermal development. To
determine whether PPARd is an important physiological
mediator of SC formation, we next examined epidermal
morphology in days 16.5, 17.5, and 18.5 PPARd knock out
(KO) and wild-type (WT) mice by light and EM. At day 16.5 of
gestation, PPARd KO mice displayed a less mature epidermis
than WT mice on H&E staining (Supplementary Figure S5, b).
Similarly, immunohistochemical staining for LOR also was
decreased in the epidermis of PPARd KO mice (Supplemen-
tary Figure S5, f), with slightly decreased INV staining
(Supplementary Figure S5, d). It is worth noting that due to
its low abundance in epidermis during fetal mouse develop-
ment, FIL was undetectable under our experimental condition
on day 16.5. Finally, EM revealed differences not only in cell
layers, but also in the extracellular matrix: while LB secretion
was comparable, formation of mature lamellar bilayers was
delayed in PPARd KO (Figure 5c-d) compared with WT
(Figure 5a-b) epidermis. Together, these results show a delay
in epidermal maturation in day 16.5 PPARd-deficient mice.
This delay in epidermal maturation persisted in day 17.5
PPARd KO mice. H&E staining (Supplementary Figure S6, b),
immunohistochemical staining for LOR (Supplementary
Figure S6, d), and EM (Figure 6), all showed a less mature
epidermis in KO compared with WT mice. However, on day
17.5, no difference in the expression levels of INV (data not
shown) or FIL (Supplementary Figure S6, e-f) was observed.
By day 18.5 and immediately after birth, there were no
differences in any parameters (data not shown) between
PPARd KO and WT mice, indicating that the delay in SC
formation is transient, occurring primary on days 16.5–17.5,
and that with time, SC development normalizes in PPARd KO
mice.
Figure 4. Intra-amniotic administration of PPARd activator accelerates
stratum corneum (SC) formation and epidermal barrier development. Timed-
pregnant Sprague–Dawley rats (day 17) were injected intra-amniotically with
either GW 610742X or vehicle, and skin samples were collected from fetal
rats on gestational day 19 for electron microscopy analysis. Pictures represent
electron micrographs of upper epidermis in dorsal skin of fetal rats.
Ruthenium tetroxide post-fixation reveals abundant lamellar unit structures in
the extracellular spaces of the SC in the epidermis of fetal rats treated with
GW 610742X (d; open arrows). Early SC formation (b) was seen in vehicle
control under low magnification; however the lamellar material was shown
unorganized (a). Mature lamellar bilayers were also presented in GW
610742X-treated rats (c; solid arrows). Bar¼ 0.25mm (d); 0.2mm
(a, c), 1 mm (b). Veh: vehicle.
WT-day 16.5 KO-day 16.5
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Figure 5. A delay in epidermal development in peroxisome proliferator-
activated receptor-d (PPARd) knockout (KO) mice at day 16.5 of gestation.
Skin biopsies were collected from wild-type (WT) and knockout (KO) fetal
mice on day 16.5, and the ultra-structure of epidermis was examined by
electron microscopy analysis. KO (cþ d) reduced lamellar bodies (arrows)
and secreted contents (arrow) in day 16.5 KO mice. WT (aþ b) stratum
corneum (SC)–stratum granulosum (SG) interface of epidermis from day 16.5
of WT mice, showing lamellar bodies (LBs) in SG cytosol (a, arrows), and
abundant secreted contents above SG (b, arrows). Bar¼ 1mm (a-b); 0.2 mm
(c-d). PD: periderm.
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DISCUSSION
Peroxisome proliferator-activated receptor-d is expressed at
high levels during embryogenesis in most tissues (Braissant
and Wahli, 1998). In the skin, PPARd is found not only in
sebaceous glands, melanocytes, and epidermal Langerhans
cells, but also throughout all layers of the epidermis (Braissant
and Wahli, 1998). Among the three PPARs, PPARd is the
most abundant isoform in the epidermis (Braissant and
Wahli, 1998). During fetal epidermal development, PPARd
is expressed in the epidermis as early as E13.5, and its
expression level increases with gestation, reaching a peak at
E18.5, which is maintained at a high level until adulthood
(Braissant et al., 1996; Braissant and Wahli, 1998; Michalik
et al., 2001). The high expression levels of PPARd during
E15.5–18.5, a period of time that coincides with the
formation of a competent barrier, and the known importance
of PPARd in epidermal differentiation and permeability
barrier homeostasis in adult skin (Westergaard et al., 2001;
Schmuth et al., 2004; Kim et al., 2006; Man et al., 2008),
suggest a potential role for this receptor in epidermal
ontogenesis.
In this study, we show that PPARd activation both
regulates and has a role in epidermal ontogenesis. First,
using our well-established fetal rat explant culture model, we
showed that treatment with the PPARd ligand, GW 610742X,
accelerates SC formation and permeability barrier develop-
ment (evidenced by both a decrease in gravimetric TEWL and
a blockade of transepidermal diffusion of fluorescence dye
Lucifer yellow). The acceleration of permeability barrier
development can be attributed to both stimulation of
corneocyte formation, and the accelerated appearance of
mature lamellar membranes in the SC. Second, the intra-
amniotic administration of GW 610742X to pregnant rats also
increased epidermal lipid synthesis/deposition, accelerated
SC formation and epidermal permeability barrier develop-
ment, in a manner very similar to what was observed in the
cultured fetal explant model. Taken together, these results
indicate that activation of PPARd accelerates epidermal
ontogenesis in rodents.
To determine whether PPARd has an important physiolo-
gical function in regulating SC formation and permeability
barrier development, we studied PPARd-deficient (KO) fetal
mice. We initially compared fetal mice from KO and WT on
day 16.5 and observed a delay in the SC formation, cornified
envelope structural protein expression (INV and LOR), as
well as delayed formation of mature lamellar bilayers in KO
fetal epidermis. At gestational day 17.5, this delay in
epidermal development persisted, but it was less severe than
observed on day 16.5. At a later gestational age (for example,
day 18.5) and at birth, there were no apparent differences in
SC formation and permeability barrier development in KO
versus WT mice. These results indicate that although PPARd
has a function in regulating fetal SC formation and perme-
ability barrier development, there are other regulating factors
that ultimately compensate for the absence of this nuclear
hormone receptor.
The fact that the absence of PPARd resulted in only a
transient delay in SC formation and permeability barrier
development was not unexpected. Previous studies have
shown that glucocorticoids (Aszterbaum et al., 1992; Hanley
et al., 1996a, 1998a), thyroid hormone (Hanley et al., 1996a,
1997a), estrogen (Hanley et al., 1996b), LXR activators
(Hanley et al., 1999; Komuves et al., 2002), and PPARa
activators (Hanley et al., 1997b, 1999, 2000a), all stimulate
SC formation and permeability barrier development. More-
over, in PPARa-deficient mice we also observed only a
transient delay in SC formation and permeability barrier
development (Schmuth et al., 2002). We would speculate
that the presence of multiple pathways that stimulate SC
formation and permeability barrier development would allow
for the absence of one pathway to be compensated for by
other regulators, thus ultimately resulting in a normal SC and
permeability barrier, which is required after birth for survival.
There are a number of different mechanisms by which
activation of PPARd could accelerate SC formation and
permeability barrier development. First, activation of PPARd
WT-day 17.5
KO-day 17.5
KO-day 17.5
Figure 6. A delay in epidermal development in peroxisome proliferator-
activated receptor-d (PPARd) knockout (KO) mice persists at day 17.5 of
gestation. Skin biopsies were collected from mild-type (WT) and KO mice on
day 17.5, and the ultra-structure of epidermis was examined by electron
microscope analysis. At 17.5 day, KO epidermis shows delayed maturation of
lamellar membranes. (a) WT mice show two-layered stratum corneum (SC),
and residual periderm (PD) layer. (b) (insert): In WT epidermis, secreted
lamellar body contents rapidly organized into elongated lamellar bilayers
(arrows). (cþ d) In KO epidermis, a two-layered SC and PD are also present,
but maturation of secreted lamellar body contents is delayed (only partially-
processed lamellae are present) (d, open arrows). SG: stratum granulosum,
TC: transitional cell. (aþ c) Osmium tetroxide post-fixation; (bþ d)
ruthenium-tetroxide fixation. Bar¼ 1mm (a, c); 0.1 mm (b, d).
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has been shown to stimulate the expression of proteins,
including INV, LOR, FIL, and transglutaminase 1 (Wester-
gaard et al., 2001; Schmuth et al., 2004), required for the
differentiation of Kers into corneocytes. The mechanism by
which activation of PPARd stimulates the expression of these
differentiation proteins is uncertain, but it could be related to
the activation of AP-1 in Kers, as we have shown for LXR
(Hanley et al., 2000b). Second, activation of PPARd
stimulates epidermal CHOL, fatty acid, and sphingolipid
synthesis (Schmuth et al., 2004; Man et al., 2006), which are
required to form LBs (Elias and Menon, 1991; Madison, 2003;
Feingold, 2007). Inhibition of either CHOL, fatty acid, or
sphingolipid synthesis results in the formation of abnormal
LBs and a failure to maintain permeability barrier home-
ostasis (Feingold et al., 1991; Holleran et al., 1991; Mao-
Qiang et al., 1993a, 1993b). Third, activation of PPARd
increases the expression of ABCA12 (Jiang et al., 2008), a
protein that is required for the transport of sphingolipids into
LBs. The absence of ABCA12 leads to harlequin ichthyosis
and lamellar ichthyosis, two devastating skin disorders
associated with abnormalities in SC formation and perme-
ability barrier function (Lefevre et al., 2003; Akiyama et al.,
2005; Kelsell et al., 2005; Akiyama, 2006). Fourth, activation
of PPARd stimulates LB secretion by SG cells (Man et al.,
2006), an essential step in the formation of the extracellular
lamellar membranes in the SC required for a normal
permeability barrier. Fifth, activation of PPARd increases b-
glucocerebrosidase activity in the SC (Man et al., 2006),
which has a key function in converting glucosylceramides to
ceramides, which are required for the formation of normal
lamellar membranes. A deficiency in b-glucocerebrosidase
activity in Gaucher’s disease or in KO mice results in the
failure to form mature lamellar membranes and abnormal
permeability barrier homeostasis (Holleran et al., 1994;
Doering et al., 1999; Mizukami et al., 2002). Pertinently,
the delayed maturation of lamellar bilayers that was noted in
KO mice could reflect decreased lipid processing. Finally,
activation of PPARd upregulates cholesterol sulfotransferase
type 2, isoform 1b expression, leading to an increase in
CHOL sulfotransferase activity resulting in the enhanced
formation of CHOL sulfate (Jiang et al., 2005). Cholesterol
sulfate has several key functions in the epidermis, including
the stimulation of Ker differentiation and the maintainance of
SC cohesion by inhibiting the enzymes that lead to SC
desquamation (Epstein et al., 1984; Downing et al., 1993;
Denning et al., 1995; Hanley et al., 2001). Thus, activation of
PPARd has numerous potential mechanisms by which it
could accelerate SC formation and permeability barrier
development (summarized in Figure 7).
In conclusion, this study shows that PPARd has a function
in SC formation and permeability barrier development.
Activation of PPARd accelerates, while the absence of PPARd
delays SC formation and permeability barrier development.
MATERIALS AND METHODS
Materials
Timed-pregnant Sprague–Dawley rats were purchased from Simon-
sen Laboratories (Gilroy, CA). GW 610742X was a gift from
Dr Timothy Willson, Glaxo Smith Kline. The tissue culture medium
(M199) was from Cellgro, Mediatech (Herndon, VA), and tissue
culture membrane inserts (Transwell-COL, 3mm pore size) were
purchased from Corning Incorporated (Corning, NY). Frozen tissue
embedding compound (OCT) was purchased from Miles Scientific
Division (Naperville, IL). Affinity-purified rabbit antibodies against
INV, LOR, and FIL were purchased from Babco (Berkeley, CA).
Organ culture
Our skin organ culture model has been described previously (Hanley
et al., 1997c). Briefly, full-thickness skin explants were removed
from estimated gestational age day 17 rat fetuses. Explants were
placed dermis side down onto collagen-coated membranes, and
submerged in 4 ml of hormone- and serum-free M199 culture media,
in the presence or absence of GW 610742X at 50–100 mM (Hanley
et al., 1996a).
Intra-amniotic injections
Timed-pregnant Sprague–Dawley rats at gestation day 17 were
anesthetized with isoforane and a ventral midline incision was
made. The uterine horns were exposed and kept moist with warm
saline, and 50 ml of GW 610742X (B1.7 mM) or vehicle (DMSO) was
injected into the amniotic fluid space of individual amniotic sacs.
Incisions in animals were immediately closed and the pregnancy
was allowed to proceed for an additional 48 hours. Fetal rats were
collected on day 19 by cesarean section and the dorsal skin were
harvested for the analysis.
PPARd KO mice
The mice used in this study were generated using a similar strategy as
described previously (Barak et al., 2002), differing only in that the WT
exon 4 was replaced with a b-galactosidase gene, rather than a
deletion, upstream of the PPARd DNA-binding domain (Chawla et al.,
2003). Homozygous lacZ knock-in mice (PPARd ki/ki) are backcrossed
four generations into the SV129 inbred strain. These mice lack almost
the entire PPARd gene product, including the DNA-binding domain.
Animals were maintained on a mouse diet (Ralston-Purina, St Louis,
MO) and water ad lib. Fetuses were obtained from either homozygous
KO or control parent mice, and the day of vaginal plug was
considered as day 0.5. Pups were delivered by cesarean sections on
days 16.5, 17.5, and 18.5 of gestation, and their weights were
carefully recorded and matched between WT and KO fetal mice
(difference iso0.3 g for morphology study ando0.1 g for EM study).
Data presented are from three independent experiments (three
breedings); each breeding includes two KO mice and two WT mice
for each time point (days 17, 18, and new born).
Immunohistochemistry
Tissue samples were fixed in 10% formaldehyde (freshly prepared
from paraformaldehyde) in phosphate-buffered saline for 24 hours and
were embedded in paraffin. Sections (5mm) were collected on
positively charged microscope slides (SuperfrostPlus, Fisher Scientific,
Pittsburgh, PA) and incubated overnight with antibodies, specific for
INV (1:1000), LOR (1:1500), or FIL (1:3000) (Komuves et al., 1999).
Microscopy and imaging
Frozen or paraffin-embedded skin sections (5mm) were stained with
H&E or nile red (Aszterbaum et al., 1992), or used for immunohis-
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tochemistry. Subsequently, slides were examined with a Zeiss light
microscope (Axioplan 2, Munich, Germany) (for H&E or immuno-
histochemistry), or a Leitz fluorescence microscope equipped for
epifluorescence (for nile red), and digital images were captured
using AxioVision software (Zeiss Vision, Mu¨nchen, Hallbergmoons,
Germany).
Electron microscopy
Parallel samples were minced into 1-mm3 pieces, fixed in modified
Karnovsky’s fixative, and processed for EM as described previously
(Hou et al, 1991). Ultrathin sections (60 nm) were contrasted with
uranyl acetate and lead citrate, and examined with a Zeiss 10 A˚electron
microscope (Carl Zeiss, Thornwood, NY) operated at 60 kV.
Permeability barrier function
In vitro gravimetric TEWL. At the end of incubation, each skin
explant was removed and cut into a single piece using an Acu-Punch
(5–6-mm in diameter) (Acuderm, Ft Lauderdale, FL) to ensure an equal
area for analysis. The sides and bottoms of the tissues were carefully
sealed to restrict water loss to solely through the epidermis, as
described previously (Nolte et al., 1993). Samples were then weighted
at 2 and 5 hours using a Cahn balance (sensitivity 0.0001 mg).
Transepidermal outside-in barrier function. Following the
treatment, explants were physically fixed in Petri dishes with edges
sealed, and incubated with 1 mM Lucifer yellow dye in phosphate-
buffered saline (pH 7.4) at 37 1C for 1 hour. Explants were then
rinsed, frozen and sectioned. The sections (5 mm) were analyzed by
fluorescence microscopy.
In vivo TEWL. Following intra-amniotic injections, fetal rats
were collected on day 19 by cesarean section and TEWL were
measured with an electrolytic water analyzer (TEWAMETER 300, Ko¨ln,
Germany).
Statistical analysis
All data are expressed as mean±SEM. Comparison between two
groups is undertaken using two-tail and unpaired t-test. Differences
in values are considered significant if Po0.05.
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